To explore the effect of the combination of bromodomain inhibitors on MM cell viability, we employed BET inhibitors JQ1 and OTX015, CPB/EP300 inhibitor SGC‐CBP30 and ISOX‐DUAL, a dual inhibitor of BET and CPB/EP300. Here, DNER is linked to Miyoshi myopathy.